secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVENUE THERAPEUTICS, INC. (ATXI)
CIK:        0001644963
Form:       8-K
Filed at:   2022-10-12T23:59:59+00:00
Accession:  0001104659-22-107952
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avenue Therapeutics closes $12M offering, net $10.4M; uses proceeds to repurchase InvaGen shares
--------------------------------------------------------------------------------

- Closed underwritten offering of 3,636,365 units at $3.30/unit; net proceeds ~$10.4M.
- Proceeds to repurchase all shares held by InvaGen Pharmaceuticals; remainder for working capital.
- Believes it now complies with Nasdaq equity requirement (min $2.5M) and bid price >$1.00 for 13 days.
- Underwriter Aegis Capital Corp. also purchased 545,454 additional warrants via over-allotment.
- Company awaiting formal Nasdaq compliance determination from Panel.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1644963/000110465922107952/0001104659-22-107952-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1644963/000110465922107952/tm2228055d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-107952

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer